<DOC>
	<DOC>NCT00543010</DOC>
	<brief_summary>A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).</brief_summary>
	<brief_title>MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>You are taking at least one medication for high blood sugar Age 21 to 80 History of Type 1 Diabetes Mellitus Currently on estrogen replacement therapy regimen Currently on a weight loss program with ongoing weight loss or taking medications for weight loss Having surgery 30 days before starting the study Have taken any other investigational drug in the past 90 days Have Hepatitis B or C Active liver or gallbladder disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>